Science & Enterprise subscription

Follow us on Twitter

  • A biotechnology company is developing treatments for cancer and other diseases using Crispr gene editing delivered… https://t.co/cZ13M2gPJk
    about 20 hours ago
  • New post on Science and Enterprise: Biotech Creating More Efficient Crispr Therapies https://t.co/JAfb7hBMoH #Science #Business
    about 20 hours ago
  • I have a Mode joke. It was a Moderna joke, but a messenger lost the RNA.
    about 2 days ago
  • Behind the scenes, CEPI and BARDA were funding vaccine development and covering manufacturing costs. They helped ge… https://t.co/4F5vMbVsrK
    about 3 days ago
  • A YouGov survey taken earlier this month indicates the U.S. public largely supports rejoining the Paris climate agr… https://t.co/eJd2v8G7K8
    about 3 days ago

Please share Science & Enterprise

Biotech Creating More Efficient Crispr Therapies

DNA puzzle

A biotechnology company is developing treatments for cancer and other diseases using Crispr gene editing delivered with more efficient synthetic proteins. . . . → Read More: Biotech Creating More Efficient Crispr Therapies

Natural-Killer Cell Cancer Therapy Biotech Launches

Natural killer cell

A new company is underway creating off-the-shelf engineered cells from the immune system as cancer treatments, and raising $42 million in venture funds. . . . → Read More: Natural-Killer Cell Cancer Therapy Biotech Launches

Nanoscale Particles Deliver Crispr Cancer Treatments

Crispr-Cas9 illustration

Researchers in Israel developed techniques to deliver gene editing therapies with lipid nanoscale particles that in lab mice killed cancer cells and increased survival. . . . → Read More: Nanoscale Particles Deliver Crispr Cancer Treatments

Cancer Immune System Therapy Start-Up Raises $53M

T-cells illustration

A company developing treatments that retune the immune system to kill solid tumor and blood-related cancers is raising $53 million in its first venture funding. . . . → Read More: Cancer Immune System Therapy Start-Up Raises $53M

Blood Cells Transport Enzymes to Slow Cancer Spread

Red blood cells and nanoparticles

Researchers devised a technique that in lab mice carries immune system enzymes on red blood cells to stop the spread of cancer in the lungs. . . . → Read More: Blood Cells Transport Enzymes to Slow Cancer Spread

Covid-19 Saliva Test Earns FDA Emergency Clearance

SARS-Cov-2 viruses

A test to detect Covid-19 viruses in saliva rather than nasal swabs received emergency authorization from Food and Drug Administration. . . . → Read More: Covid-19 Saliva Test Earns FDA Emergency Clearance

Personal Cancer Vaccine Induces Tumor Shrinkage

Julie Bauman

Interim results from a clinical trial show some head and neck cancer patients receiving a personalized vaccine and immunotherapy report tumor shrinkage. . . . → Read More: Personal Cancer Vaccine Induces Tumor Shrinkage

Better Precision Medicine Outcomes Shown for Leukemia

DNA analysis graphic

Clinical trial results show a strategy that first tests for genomic mutations to guide treatments results in better outcomes for patients with acute myeloid leukemia. . . . → Read More: Better Precision Medicine Outcomes Shown for Leukemia

Precision Drug Trial Shows Solid Tumor Shrinkage

Cancer on clipboard

Partial results from a clinical trial show a drug to stop specific cancer-causing proteins shrinks advanced tumors in some patients across several tumor types. . . . → Read More: Precision Drug Trial Shows Solid Tumor Shrinkage

Start-Up Developing Engineered B-Cell Therapies

Human B-cell

A new enterprise, spun off from Seattle Children’s Research Institute, is creating therapeutics for diseases from engineered B-cells in the immune system. . . . → Read More: Start-Up Developing Engineered B-Cell Therapies